Browsing by Author Doan, N.B.

Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)
15-Nov-2010Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiformeYin, D.; Chen, W.; O'Kelly, J.; Lu, D.; Ham, M.; Doan, N.B.; Xie, D.; Wang, C.; Vadgama, J.; Said, J.W.; Black, K.L.; Koeffler, H.P. 
Jun-2010Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancerIwanski, G.B.; Lee, D.H.; En-Gal, S.; Doan, N.B.; Castor, B.; Vogt, M.; Toh, M.; Bokemeyer, C.; Said, J.W.; Thoennissen, N.H.; Koeffler, H.P. 
15-May-2012Inecalcitol, an analog of 1α,25(OH) 2D 3, induces growth arrest of androgen-dependent prostate cancer cellsOkamoto, R.; Delansorne, R.; Wakimoto, N.; Doan, N.B.; Akagi, T.; Shen, M.; Ho, Q.H.; Said, J.W.; Koeffler, H.P. 
May-2013Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancerSudo, M.; Chin, T.M. ; Mori, S.; Doan, N.B.; Said, J.W.; Akashi, M.; Koeffler, H.P.
Jan-2014Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFRGarg, M.; Kanojia, D.; Okamoto, R.; Jain, S.; Jain, V.; Chien, W. ; Sampath, A.; Ding, L.-W. ; Xuan, M.; Said, J.W.; Doan, N.B.; Liu, L.-Z.; Yang, H.; Gery, S.; Braunstein, G.D.; Koeffler, H.P.
28-Feb-2013MiR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiformeYin, D.; Ogawa, S.; Kawamata, N.; Leiter, A.; Ham, M.; Li, D.; Doan, N.B.; Said, J.W.; Black, K.L.; Phillip Koeffler, H. 
Jan-2013Off-target effects of c-MET inhibitors on thyroid cancer cellsZhou, Y.; Zhao, C.; Gery, S.; Braunstein, G.D.; Okamoto, R.; Alvarez, R.; Miles, S.A.; Doan, N.B.; Said, J.W.; Gu, J.; Phillip Koeffler, H. 
2013Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survivalLee, D.H.; Amanat, S.; Goff, C.; Weiss, L.M.; Said, J.W.; Doan, N.B.; Sato-Otsubo, A.; Ogawa, S.; Forscher, C.; Koeffler, H.P. 
1-Oct-2013PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cellsChien, W. ; Lee, K.L. ; Ding, L.W. ; Wuensche, P.; Kato, H.; Doan, N.B.; Poellinger, L. ; Said, J.W.; Koeffler, H.P.
28-Jul-2011Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcomaLee, D.H.; Thoennissen, N.H.; Goff, C.; Iwanski, G.B.; Forscher, C.; Doan, N.B.; Said, J.W.; Phillip Koeffler, H. 
15-Jun-2013The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancerAribi, A.; Gery, S.; Lee, D.H.; Thoennissen, N.H.; Thoennissen, G.B.; Alvarez, R.; Ho, Q.; Lee, K.; Doan, N.B.; Chan, K.T.; Toh, M.; Said, J.W.; Koeffler, H.P. 
Aug-2012Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphomaThoennissen, N.H.; Thoennissen, G.B.; Abbassi, S.; Nabavi-Nouis, S.; Sauer, T.; Doan, N.B.; Gery, S.; Müller-Tidow, C.; Said, J.W.; Koeffler, H.P.